Business Context and Reporting Period
Company: Marchex, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 5, 2014
Reporting Period: Quarter ended June 30, 2014
Context: The filing announces the issuance of a press release and a conference call regarding the company's financial results for the second quarter of 2014.
Key Financial Metrics
The provided text is a cover document (Form 8-K) referencing a press release (Exhibit 99.1) containing the actual financial data. Consequently, the filing text does not provide clear values for the following metrics:
- Revenue
- Profit (Net Income/Loss)
- Cash Flow
- Margins
- Debt
- Liquidity
The filing notes that the company is referencing non-GAAP financial measures in the press release and conference call, with reconciliations to GAAP measures included in the attached exhibit.
Material Changes
The filing text does not contain specific data regarding material changes versus the prior comparable period. Investors must refer to the attached Press Release (Exhibit 99.1) for comparative analysis.
Guidance, Outlook, and Risks
Management Commentary: Management is holding a conference call to discuss the results. The filing explicitly states that the information in Item 2.02 and Exhibit 99.1 is "furnished" and not "filed" for purposes of Section 18 of the Exchange Act, meaning it is not subject to the liabilities of that section and will not be incorporated by reference into other registration statements unless expressly stated.
Risks and Contingencies: No specific risks or contingencies are detailed in this cover document.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, profit, and cash flow figures for the quarter ended June 30, 2014.
- Examine the reconciliation of non-GAAP financial measures to GAAP measures provided in the press release.
- Verify the definitions of non-GAAP measures used by management and the rationale for their use.
- Confirm whether the "furnished" status of the data impacts its legal standing in future litigation or regulatory reviews.